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with condoms only (adjusted odds ratio,
[AOR] = 3.01; 95% conﬁdence interval
[CI] = 1.96 to 4.64) and less likely to
prefer both methods compared with con-
doms only (AOR = 0.63; CI = 0.45 to
0.89). Men from Fort Lauderdale (vs.
Chicago) were less likely to prefer PrEP
compared with condoms (P , 0.05). No
differences were found for race/ethnicity,
age, or education in regression models for
the full sample (P . 0.05).
In stratiﬁed multivariable analyses
by risk behavior (Table 1), among par-
ticipants who reported recent anal sex
without a condom, men aged 18–29 (vs.
40+) were less likely to prefer PrEP
compared with condoms only (AOR =
0.42; CI = 0.22 to 0.77) and more likely
to prefer both methods compared with
condoms only (AOR = 2.44; CI = 1.30 to
4.58). Men from Fort Lauderdale (vs.
Chicago) were less likely to prefer PrEP
compared to condoms within both sub-
groups of men who did and did not report
recent risk behavior (P, 0.05). No other
within-group demographic differences
were found.
Although several demographic and
risk behavioral differences in prevention
method preferences were observed for
the sample in bivariate analyses, differ-
ences in multivariable regression analy-
ses were narrowed to MSM reporting
recent risk behavior and Fort Lauderdale
residence when controlling for other
demographic characteristics. Speciﬁcally,
MSM reporting recent risk behavior pre-
ferred PrEP to condoms and were less
likely to prefer using both methods over
condoms, compared with men not report-
ing risk behavior. It is unsurprising that
MSM not using condoms would be more
likely to prefer using PrEP to condoms,
which represents an increase in protection
for these individuals. At the same time,
condom users preferred additional pro-
tection in conjunction with condoms,
which also represents an increase in
protection for those individuals. The
increased protection among condom
users and nonusers does not support the
concern of risk compensation.
Of keen interest is that among the
MSM who reported recent risk behavior,
younger men were more likely to prefer
using both methods over condoms alone,
which would provide additional protection
to this group at particularly high risk of
HIV infection.1 Simultaneously, older men
with recent risk behavior preferred PrEP
over condoms. Geographical differences
in preferences were also noteworthy.
This cross-sectional analysis is lim-
ited in that it assessed prevention method
preferences and not actual behavior over
time. Furthermore, preferences for using
PrEP in the future obviously do not take
into account adherence and uptake,
although we do know about recent con-
domless anal sex and we included that
consideration in this analysis. The study
is limited to black and Latino MSM at
highest risk for infection. Further research
is needed on these populations in US
cities beyond those represented here and
with diverse samples of MSM.
More black and Latino MSM pre-
ferred using both PrEP and condoms to
either method singularly, especially
younger men. This ﬁnding is contrary
to a concern of risk compensation.5 This
study reports promising potential for
enhanced protection with PrEP among
both current condom users and nonusers.
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Achieving Pregnancy
Safely in HIV-Affected
Individuals and
Couples: An Important
Strategy to Eliminate
HIV Transmission
From Mother-To-Child
and Between
Sexual Partners
*For the purpose of this letter an
HIV-affected individual/couple refers
to person(s) living in an HIV endemic
region where one person is HIV-infected
or of unknown HIV status; **timed
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condomless intercourse refers to sexual
intercourse without a condom timed to
peak fertility during ovulation and/or in
combination with antiretroviral therapy
(ART) in the HIV-infected partner and/
or PrEP for the uninfected partner.
To the Editors:
HIV-infected individuals are living
longer, more productive lives. HIV-
affected individuals and couples experi-
ence personal and social desires to
reproduce for all the same reasons as
uninfected individuals and couples,1 and
thus require safe reproductive options.
HIV prevention interventions often do
not consider the childbearing desires of
HIV-affected individuals or couples, espe-
cially in low- and middle-income countries
(LMICs). Failure to assist women with
desired fertility can contribute to continued
HIV transmission and must be addressed
within national elimination of mother-to-
child transmission (eMTCT) strategies.
A human rights perspective suggests
that HIV-affected couples* should have
the same ability to choose if and when to
have children as HIV-unaffected couples,
including access to pre-pregnancy
counseling, contraceptives, and, when
needed, abortion services. This holistic
view includes assistance in mitigating
HIV transmission risk when children are
desired. In high-income countries, HIV-
affected individuals and couples have
access to an array of options: (1) treat-
ment of the HIV-infected partner as pre-
vention of transmission to the uninfected
partner in conjunction with timed con-
domless intercourse2**; (2) preexposure
prophylaxis (PrEP) for the uninfected
partner3; (3) assisted reproductive serv-
ices, including timed vaginal insemina-
tion and sperm washing with intrauterine
insemination or in-vitro fertilization4,5;
(4) sperm donation; and (5) adoption.1,6
In contrast, access to methods of
becoming pregnant in LMICs are limited
by cost, availability, and sometimes a lack
of appreciation by policymakers of the
desires and rights of HIV-affected individ-
uals/couples to have children safely.
Simple fertility methods may not be
discussed as a component of routine
HIV care and treatment counseling due to
a lack of awareness or knowledge about
their safety, affordability, or efﬁcacy.7 To
enhance the armamentarium of HIV pre-
vention and reproductive services to
achieve zero perinatal and sexual trans-
mission, “safer conception”, and fertility
services should be integrated into existing
PMTCT strategies.
The existing four-pronged preven-
tion of mother-to-child transmission
(PMTCT) strategy, developed by the
World Health Organization (WHO), in-
cludes (1) prevention of HIV in women
of reproductive age; (2) prevention of
unintended pregnancy in women with
HIV; (3) prevention of HIV transmission
from mother to child; and (4) the pro-
vision of ongoing care and support to
mothers, their children, and their fami-
lies.8 All four prongs are rooted in pre-
vention of sexual and perinatal HIV
transmission, HIV testing, use of ART
for mothers and infants, exclusive breast-
feeding, and access to contraceptive
services. The continuum of care services
are included within the third WHO
prong, including antenatal, intrapartum,
and postpartum/postnatal health care
services (Fig. 1). However, provision of
education and clinical services for achiev-
ing pregnancy safely is not uniquely
addressed in the current WHO eMTCT
strategy,8 and we believe that they should
be included within the continuum of care
services of the third prong of the strategy
that addresses: “prevention of HIV trans-
mission from mother to child.”
FIGURE 1. Redefining the prevention/eMTCT
strategy.
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NEW KNOWLEDGE ON SAFER
PRE-PREGNANCY OPTIONS AS
HIV INTERVENTIONS
In order to broaden our reach in HIV
prevention, we propose this new approach
within the existing prevention strategy to
expand fertility service options that will
address all the reproductive desires of
HIV-affected individuals and couples.
They need positive guidance and support
from health care providers to minimize
sexual HIV transmission. Without this
assistance in achieving pregnancy safely,
HIV-affected individuals and couples risk
HIV transmission to the uninfected partner,
especially in the absence of ART, viral
suppression, and/or PrEP.9 The eMTCT
spectrum of care provides an ideal con-
struct for the inclusion of pre-pregnancy
services particularly when engagement of
the male partner is achieved to reduce the
risk of HIV transmission to the uninfected
partner and developing fetus. To achieve
this, advocacy groups will also need to call
for policy changes to include the integra-
tion of couples counseling and fertility
service options for achieving pregnancy
safely into existing HIV care and pre-
vention strategies.
PROBLEM TO BE ADDRESSED
More than 35 million people world-
wide live with HIV, and up to 60% of
new HIV infections occur in HIV-
serodiscordant partnerships.10,11 In Ken-
ya alone, there are an estimated 260,000
HIV-serodiscordant couples.12 In order to
reduce mother-to-child transmission in
Kenya to below 5% by the end of
2015, greater than 90% of HIV-
infected women need to be identiﬁed,
treated with ART, and offered other
HIV prevention interventions.13 The
assurance of comprehensive reproduc-
tive care services that addresses the
spectrum of reproductive health care
needs across an HIV-infected individ-
ual’s life cycle is a component that
is missing from current programs,
largely due to the ignorance of their
value as essential to reducing hetero-
sexual and subsequent vertical trans-
mission of HIV.
Before expanded access to effec-
tive ART, health care providers actively
discouraged HIV-affected women from
becoming pregnant.14 Although ART
is now more accessible in sub-Saharan
Africa, one report documented that less
than half of known HIV-infected individ-
uals in Kenya achieved viral suppression
(ie, HIV RNA,1000 copies).12 Similarly,
only 30% of all HIV-infected individuals
in the United States are virally suppressed
as per the most recent estimates.15
Despite the shift in reproductive
guidelines supporting pregnancy in HIV-
affected persons,16–21 most health care
facilities in sub-Saharan Africa do
not offer safer options for couples
attempting to become pregnant.22,23
HIV-infectedwomenwho express a desire
for children often encounter the disap-
proval of their communities and/or health
care workers.23
COMPREHENSIVE
eMTCT/PMTCT STRATEGY
Incorporating pre-pregnancy and
“safer conception” services into eMTCT
(Fig. 1) allows healthy HIV-affected
individuals to choose to achieve their
reproductive goals of childbearing
while minimizing risks of HIV transmis-
sion from or to their uninfected partners.
Lower-cost assisted fertility interventions
for achieving pregnancy safely include
initiation of lifelong ART for the HIV-
infected partner and/or PrEP for the HIV-
uninfected partner. Other approaches
include timed vaginal insemination or
sperm washing with intrauterine insemina-
tion. To achieve success in global HIV
prevention, a combination of interventions
incorporating behavioral and biomedical
interventions are required. Hence, treat-
ment as prevention (ie, starting ART to
prevent HIV transmission) coupled with
timed condomless intercourse, with or
without PrEP, should not be the only
option for HIV-affected individuals and
couples desiring children. These inter-
ventions require continued engagement
in care—adherence to ART and/or
PrEP as well as HIV viral load mon-
itoring for the HIV-infected partner
(Table 1). Regardless, the goals for
reproductive health programs for HIV-
serodiscordant couples need to both
help protect the HIV-uninfected partner
while ensuring the autonomy of the
HIV-infected partner through the use
of multiple options to achieve preg-
nancy safely. Finally, to address HIV-
related stigma and close the gap in
health care services, health care providers
must be equipped with training, educa-
tional materials, and the clinical supplies
required to provide safer pre-pregnancy
services for HIV-affected couples
desiring children.
Prevention of HIV transmission
to the uninfected male partner in
female-positive HIV-serodiscordant
couples is critical to ensuring male
partner involvement and improved suc-
cess of eMTCT interventions at the
community level.24 In sub-Saharan
Africa, men possess social and eco-
nomic power, and often play a major
role in their partners’ health decision
making.25 For example, successful
uptake and integration of contraceptive
services into HIV care and treatment in
TABLE 1. Interventions for Achieving Pregnancy Safely in HIV-Affected Couples*
Treatment as Prevention
With Timed Condomless
Intercourse PrEP SW-IUI TVI
Environment
High-income country† d d d d
Low- and middle-income
country†
d ‡ ‡ d
HIV-serodiscordant couple
♂+/♀−§ d d d
♂−/♀+§ d d d
Estimated risk reduction 95%2 63%–73%3 100%4,5 100%
*Screening and treatment of sexually transmitted diseases decrease the risk of HIV transmission/acquisition,
estimated risk reduction up to 40%.
†World Bank Classiﬁcation.
‡Not readily available in low- and middle-income country prepared by Sarah Block.
§HIV viral RNA suppression should be assured, if possible.
SW-IUI, sperm washing with intrauterine insemination; TVI, timed vaginal insemination.
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Kenya was accelerated by the accep-
tance and participation of the male
partner.26 Similarly, the extent to
which male partner involvement can
facilitate the uptake and adaptation of
pre-pregnancy services requires
research within the eMTCT strategy.27
FUTURE DIRECTIONS
Achieving the ambitious goal of
zero HIV transmission to unborn chil-
dren and sexual partners requires
enhancement of the existing eMTCT
strategy. To achieve this, advocacy
groups need to call for policy changes
that integrate couples counseling and fer-
tility service options into existing HIV care
and prevention strategies. An interdisci-
plinary approach, inclusive of health care
providers and administrators, policy mak-
ers, laboratory staff, researchers, donors,
and community members, is critical to the
integration and acceptance of lower cost
and safer reproductive options into the
eMTCT strategy for HIV-affected couples
desiring children.28,29 These stakehold-
ers should work together to promote
the development of evidence-based
clinical guidelines to support and inte-
grate reproductive services into HIV
care and treatment programs. At any
given time along the reproductive
spectrum, safer conception options
must be recognized as a critical priority
element of any comprehensive “family
planning” initiative that are currently
viewed only through the prism of
contraception, child spacing, and
access to safe abortion.
We encourage support for research
on, and implementation of, safer pre-
pregnancy interventions, including
funding for the development and dissem-
ination of educational training materials
for health care providers that are rele-
vant to LMICs.22 In the changing con-
text of ART initiation guidelines, we
must accept that some HIV-infected
individuals will make the choice to
delay ART.30,31 Respecting their auton-
omy and decision making requires the
provision of safer pre-pregnancy op-
tions that may include ART and/or
PrEP. Recognition and support of the
childbearing desires and reproductive
rights of HIV-affected individuals and
couples require that fertility services be
made accessible, affordable, and inte-
grated into the prevention and eMTCT
care continuum.
Okeoma Mmeje, MD, MPH*
Betty Njoroge, MBChB, MPH†
Craig R. Cohen, MD, MPH‡
Marleen Temmerman,
MD, MPH, PhD§
Sten H. Vermund, MD, PhDk
Sheryl van der Poel, MD, PhD§
*Department of Obstetrics and Gynecology,
University of Michigan School of Medicine,
Ann Arbor, MI
†Kenya Medical Research Institute
(KEMRI), Centre for Microbiology Research
(CMR) Nairobi, Kenya
‡Department of Obstetrics, Gynecology and
Reproductive Sciences, Bixby Center for
Global Reproductive Health, University of
California, San Francisco, CA
§Division of Reproductive Health and
Research, World Health Organization,
Geneva, Switzerland
kVanderbilt Institute for Global Health and
Department of Pediatrics, Vanderbilt
University School of Medicine,
Nashville, TN
REFERENCES
1. Matthews LT, Mukherjee JS. Strategies for harm
reduction among HIV-affected couples who want
to conceive. AIDS Behav. 2009;13(suppl 1):5–11.
2. Cohen MS, Gay CL. Treatment to prevent
transmission of HIV-1. Clin Infect Dis. 2010;
50(suppl 3):S85–S95.
3. Baeten JM, Donnell D, Ndase P, et al. Anti-
retroviral prophylaxis for HIV prevention in
heterosexual men and women. N Engl J Med.
2012;367:399–410.
4. Semprini AE, Levi-Setti P, Bozzo M, et al.
Insemination of HIV-negative women with
processed semen of HIV-positive partners.
Lancet. 1992;340:1317–1319.
5. Savasi V, Mandia L, Laoreti A, et al. Repro-
ductive assistance in HIV serodiscordant
couples. Hum Reprod Update. 2013;19:
136–150.
6. Mmeje O, Cohen CR, Cohan D. Evaluating
safer conception options for HIV-serodiscordant
couples (HIV-infected female/HIV-uninfected
male): a closer look at vaginal insemination.
Infect Dis Obstet Gynecol. 2012;2012:587651.
7. Mmeje O, van der Poel S, Workneh M, et al.
Achieving pregnancy safely: perspectives on
timed vaginal insemination among HIV-
serodiscordant couples and health-care pro-
viders in Kisumu, Kenya. AIDS Care. 2015;
27:10–16.
8. Hayashi C, Shaffer N, Souteyrand Y. Global
Monitoring Framework and Strategy for the
Global Plan Towards the Elimination of
New HIV Infections Among Children by
2015 and Keeping Their Mothers Alive
(EMTCT); 2012. World Health Organization.
http://apps.who.int/iris/bitstream/10665/75341/
1/9789241504270_eng.pdf. Accessed July 8,
2015.
9. Brubaker SG, Bukusi EA, Odoyo J, et al.
Pregnancy and HIV transmission among HIV-
discordant couples in a clinical trial in Kisu-
mu, Kenya. HIV Med. 2011;12:316–321.
10. Joint United Nations Programme on HIV.
UNAIDS Report on the Global AIDS Epidemic
2013. 2013. Available at: http://www.unaids.
org/en/resources/campaigns/globalreport2013/
globalreport. Accessed July 8, 2015.
11. Dunkle KL, Stephenson R, Karita E, et al. New
heterosexually transmitted HIV infections in
married or cohabiting couples in urban Zambia
and Rwanda: an analysis of survey and clinical
data. Lancet. 2008;371:2183–2191.
12. National AIDS and STI Control Programme,
Ministry of Health, Kenya. Kenya AIDS
Indicator Survey 2012: Preliminary Report;
2013. Available at: http://www.faces-kenya.
org/2013/09/preliminary-report-for-kenya-aids-
indicator-survey-2012/. Accessed July 8, 2015.
13. Sirengo M, Muthoni L, Kellogg TA, et al.
Mother-to-child transmission of HIV in Ken-
ya: results from a nationally representative
study. J Acquir Immune Deﬁc Syndr. 2014;66
(suppl 1):S66–S74.
14. Chadwick RJ, Mantell JE, Moodley J, et al.
Safer conception interventions for HIV-affected
couples: implications for resource-constrained
settings. Top Antivir Med. 2011;19:148–155.
Available at: http://www.ncbi.nlm.nih.gov/
pubmed/22156217. Accessed July 8, 2015.
15. Bradley H, Hall HI, Wolitski RJ, et al. Vital
Signs: HIV diagnosis, care, and treatment
among persons living with HIV—United States,
2011.MMWRMorb Mortal Wkly Rep. 2014;63:
1113–1117. Available at: http://www.cdc.gov/
mmwr/preview/mmwrhtml/mm6347a5.htm?s_
cid=mm6347a5_w. Accessed July 8, 2015.
16. Africa D of HR of S. National Contraception
and Fertility Planning Policy and Service
Delivery Guidelines. Pretoria; 2012. Available
at: http://www.health-e.org.za/wp-content/
uploads/2014/05/National-contraception-family-
planning-policy.pdf. Accessed July 8, 2015.
17. Clutterbuck DJ, Flowers P, Barber T, et al. UK
national guideline on safer sex advice. Int J
STD AIDS. 2012;23:381–388.
18. Bekker L, Black V, Myer L, et al. Guideline on
safer conception in fertile HIV-infected individuals
and couples. South J HIV Med. 2011;12:31–44.
19. Weber S, Waldura JF, Cohan D. Safer con-
ception options for HIV serodifferent couples
in the United States: the experience of the
National Perinatal HIV Hotline and Clini-
cians’ Network. J Acquir Immune Deﬁc Syndr.
2013;63:e140–e141.
20. Panel on Treatment of HIV-Infected Pregnant
Women and Prevention of Perinatal Trans-
mission. Recommendations for Use of Antire-
troviral Drugs in Pregnant HIV-1-Infected
Women for Maternal Health and Interventions
to Recommendations for Use of Antiretroviral
Drugs in Pregnant HIV-1-Infected Women for
Maternal Health and Interventions to Reduce
Perinatal HIV Transmission in the United States;
2014. Available at: http://aidsinfo.nih.gov/
contentﬁles/lvguidelines/PerinatalGL.pdf. Ac-
cessed July 8, 2015.
Letters to the Editor J Acquir Immune Defic Syndr  Volume 70, Number 4, December 1, 2015
e158 | www.jaids.com Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.5
21. Loutfy MR, Margolese S, Money DM, et al.
Canadian HIV pregnancy planning guide-
lines. J Obstet Gynaecol Can. 2012;34:575–
590. Available at: http://www.ncbi.nlm.nih.
gov/pubmed/23125998. Accessed July 8,
2015.
22. Myer L, Morroni C, Cooper D. Community
attitudes towards sexual activity and child-
bearing by HIV-positive people in South
Africa. AIDS Care. 2006;18:772–776.
23. Kaida A, Laher F, Strathdee SA, et al. Child-
bearing intentions of HIV-positive women of
reproductive age in Soweto, South Africa: the
inﬂuence of expanding access to HAART in an
HIV hyperendemic setting. Am J Public Health.
2011;101:350–358.
24. The Inter-Agency Task Team for Prevention and
Treatment of HIV Infection in Pregnant Women,
Mothers and Their Children. Preventing HIV
and Unintended Pregnancies : Strategic Frame-
work 2011-2015; 2012. Available at: http://
www.unfpa.org/publications/preventing-hiv-and-
unintended-pregnancies-strategic-framework-
2011-2015. Accessed July 8, 2015.
25. Dunlap J, Foderingham N, Bussell S, et al. Male
involvement for the prevention of mother-to-
child HIV transmission: a brief review of
initiatives in East, West, and Central Africa.
Curr HIV/AIDS Rep. 2014;11:109–118.
26. Grossman D, Onono M, Newmann SJ, et al.
Integration of family planning services into HIV
care and treatment in Kenya: a cluster-randomized
trial. AIDS. 2013;27(suppl 1):S77–S85.
27. Aliyu M, Blevins M, Audet CM, et al. Opti-
mizing PMTCT service delivery in rural North
Central Nigeria: protocol and design for a cluster
randomized study. Contemp Clin Trials. 2013;
36:187–197.
28. Breitnauer BT, Mmeje O, Njoroge B, et al.
Community perceptions of childbearing and
use of safer conception strategies among HIV-
discordant couples in. J Int AIDS Soc. 2015;
18:1–7.
29. Mmeje O, Titler M, Dalton V. A call to action:
evidence-based safer conception interventions
in HIV-affected couples desiring children in
sub-Sharan africa. Int J Gynecol Obstet. 2014;
128(1):73–74.
30. Curran K, Ngure K, Shell-Duncan B, et al.
“If I am given antiretrovirals I will think I
am nearing the grave”: Kenyan HIV sero-
discordant couples’ attitudes regarding early
initiation of antiretroviral therapy. AIDS.
2014;28:227–233.
31. Roberts ST, Heffron R, Ngure K, et al. Prefer-
ences for daily or intermittent pre-exposure
prophylaxis regimens and ability to anticipate
sex among HIV uninfected members of Kenyan
HIV serodiscordant couples. AIDS Behav.
2014;18:1701–1711.
J Acquir Immune Defic Syndr  Volume 70, Number 4, December 1, 2015 Letters to the Editor
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. www.jaids.com | e159
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.5
